Research Article | Open Access
Marzena Tylicka, Ewa Matuszczak, Joanna Kamińska, Wojciech Dębek, Beata Modzelewska, Tomasz Kleszczewski, Violetta Dymicka-Piekarska, Joanna Matowicka-Karna, Maria Karpińska, Olga M. Koper-Lenkiewicz, "Intraoperative Peritoneal Interleukin-6 Concentration Changes in Relation to the High-Mobility Group Protein B1 and Heat Shock Protein 70 Levels in Children Undergoing Cholecystectomy", Mediators of Inflammation, vol. 2020, Article ID 9613105, 9 pages, 2020. https://doi.org/10.1155/2020/9613105
Intraoperative Peritoneal Interleukin-6 Concentration Changes in Relation to the High-Mobility Group Protein B1 and Heat Shock Protein 70 Levels in Children Undergoing Cholecystectomy
The aim was the evaluation of IL-6 concentration in peritoneal lavage fluid of children which underwent cholecystectomy to ascertain if there is a difference in early inflammatory response depending on the type of surgical approach (open vs. laparoscopy). The analysis of high-mobility group protein B1 (HMGB1) and heat shock protein 70 (HSP70) was performed to find out if the source of IL-6 was related to tissue damage. IL-6 concentration in peritoneal lavage fluid samples, obtained at the beginning and at the end of the laparoscopic () and open cholecystectomy (), was tested with a routinely used electrochemiluminescence assay. The concentrations of HMGB1 and HSP70 were analyzed with the use of an ELISA method. Statistical analysis was performed using the STATISTICA PL release 12.5 Program. The differences were assessed using the Mann-Whitney test and Wilcoxon matched pairs test. Correlations were studied by using the Spearman correlation test. Our results demonstrated significant peritoneal lavage fluid IL-6 concentration growth measured at the end of the cholecystectomy as compared to the beginning, regardless of the type of the procedure. IL-6 growth during open cholecystectomy was greater compared to laparoscopic cholecystectomy (62.51-fold vs. 3.19-fold). IL-6 concentration did not correlate with HMGB1 and HSP70, which indicate that the significant growth of this cytokine was not related to mechanical tissue damage due to surgical procedure. A clinical significance of the study could be related to the fact that the evaluation of IL-6 concentration in peritoneal lavage fluid may be useful to assess an early local inflammatory response.
Cholecystectomy is a common surgery performed using the open or laparoscopic approach. It is established that the laparoscopic cholecystectomy is more beneficial compared to the open surgery procedure [1–4]. On the other hand, in the available literature, there are some voices indicating laparoscopic intervention as equivalent or even inferior compared to open surgery . Despite the type of the surgery, both operations include mechanical tissue injury, local hemorrhage, ischemia, ischemia-cellular stress, and hypoxia-reperfusion injury which altogether cause the activation of innate and adaptive immunity. The most common implications of these events are impaired wound healing and infections leading to longer hospitalization time, impaired long-term cognitive functions, and increased mortality .
IL-6 is the main cytokine produced in response to inflammatory agents and tissue injury [7, 8]. It is produced by different types of cells: monocytes/macrophages, T cells, epithelial cells, stromal cells, muscle cells, and hematopoietic cells [9, 10]. During abdominal operation, peritoneal macrophages are activated and release proinflammatory cytokines (including IL-6) into the peritoneal fluid, which may promote adhesion formation . Studies of Saba et al.  on a mouse model reveal that selective immunosuppression, using IL-6 neutralizing antibodies preoperatively, leads to a reduction of adhesion formation. Cheong et al.  highlighted the importance of inflammatory cytokine concentration evaluation in peritoneal lavage fluid immediately after the operation.
Damage-associated molecular patterns (DAMPs) are released from dying or damaged cells occurring as a result of so-called “sterile inflammation,” caused, i.e., by trauma, burn, or ischemia [7, 13]. Among DAMPs, which are able to directly and indirectly promote inflammatory process, we can distinguish high-mobility group protein B1 (HMGB1), heat shock proteins (HSPs), mitochondrial (mt) DNA, and others [14, 15]. Study of Bianchi  shows that mtDNA leads to Toll-like receptor (TLR) 9 and NF-kappa beta (NF-κB) activation, which is recognized as a transcription factor regulating human IL-6 gene transcription, as cis-regulatory elements in the IL-6 gene 5 flanking region have binding sites for NF-κB .
Currently, in routine laboratory diagnostics, inflammatory process after surgery can be monitored by the white blood cell count (WBC) and C-reactive protein (CRP) concentration evaluation [6, 17]. Literature data indicates that the levels of circulating plasma proinflammatory cytokines, including IL-6, may be related to the extent and severity of surgical procedure [18–22]. Moreover, available literature indicates that peak in IL-6 production or messenger RNA (mRNA) IL-6 and their kinetics differ depending on causative agent and research model (e.g., human/animal model, type of sample: serum, plasma, urine, whole blood, adipose tissue, skeletal muscle) [23–32]. The intraoperative peritoneal fluid IL-6 concentration changes in open versus laparoscopic cholecystectomy have not been widely studied so far. Thus, the aim of the study was the evaluation of IL-6 concentration in peritoneal lavage fluid of children, which underwent cholecystectomy to find out a difference in early local inflammatory response depending on the type of intervention (laparoscopy or open). Furthermore, we analyzed concentrations of selected DAMPs (HMGB1 and HSP70) to assess if the source of IL-6 was related to mechanical tissue damage.
2. Material and Methods
Thirty-seven of forty children, who were admitted between 2013 and 2017 to the Pediatric Surgery Department of the Medical University of Bialystok for possible cholecystectomy, were included in the study. Inclusion criterion was patients’ age between 4 and 17 years. Study group was divided by taking into consideration the procedure used to perform cholecystectomy: open surgery group () and laparoscopic surgery group ().
Criteria for performing laparoscopic cholecystectomy were as follows: (a) , (b) low risk for common bile duct (CBD) stones, as defined by normal liver enzymes and common bile duct diameter of 5 mm or less, (c) elective operation, (d) absence of major medical problems, and (e) no previous upper abdominal operations. Criteria for performing open cholecystectomy were and previous abdominal operations which prevent safe abdominal access.
Three children were excluded from the analysis because of exclusion criteria: oncological history, severe existing infections, and immunological or cardiovascular diseases that required long-term medication. Those patients, whose parents gave informed consent for both clinical and biochemical follow-ups, were included in the study.
During cholecystectomy, intraoperative drainage of the peritoneal cavity with routinely used normal saline (0.9% NaCl) was performed. Normal saline has gained wide popularity in abdominal surgery and is used to remove cells, tissue debris, or blood clots. All patients at the beginning and at the end of the laparoscopic and open cholecystectomy underwent peritoneal lavage. Immediately after incision (at the beginning) and before closure (at the end), normal saline was poured into the peritoneal cavity and was aspirated back into a syringe. The amount of 0.9% NaCl solution applied to the lavage of the peritoneum was 3.5 mL per kilogram of the patient’s body mass (; IQs: 49.00-210.00 mL), of which about 90% of fluid was aspirated back (during surgery condition, it is not possible to aspirate back the whole volume of the liquid). 10 mL each of liquid aspirated from the peritoneal lavage at the beginning and at the end of surgery was taken to the experiment.
Patients received standard surgical care and postoperative treatment after surgical approach according to the standard treatment protocols of our clinic and were given intravenous paracetamol after the surgeries which does not suppress the inflammation .
Approval for this study was obtained from the Local Bioethics Committee (Permission No.: R-I-002/471/2018). Procedures were in accordance with the ethical standards set by the Declaration of Helsinki given by the World Medical Association.
2.2. IL-6, HMGB1, and HSP70 Concentrations’ Measurement
The concentration of IL-6 in peritoneal lavage fluid was tested on the COBAS e411 immunochemical analyzer (Roche Diagnostics) by means of IVD (in vitro diagnostics) test using the electrochemiluminescence immunoassay (ECLIA) method. Peritoneal lavage fluid samples were not diluted prior to analysis. The assay range was to equal 1.5-5000 pg/mL (determined by the lower limit of detection and the highest point of the standard curve). According to the manufacturer’s instructions, the following cytokines IL-1α, IL-1β, IL-2, IL-3, IL-4, IL-8, interferon-γ, and tumor necrosis factor-α in the concentration of 50 ng/mL do not show cross reactions.
The concentrations of high-mobility group protein B1 (HMGB1) and heat shock protein 70 (HSP70) in peritoneal lavage fluid samples were analyzed with the use of an ELISA (enzyme-linked immunosorbent assay) method, as described elsewhere .
HMGB1 concentration was measured using an EIAB Human HMGB1/high-mobility group protein B1 ELISA kit (Catalogue No. E0399h) in compliance with the manufacturer’s instructions. Peritoneal lavage fluid samples were not diluted prior to analysis. The detection range for the kit is between 0.156 and 10.00 ng/mL. According to the manufacturer’s instruction, the sensitivity (minimum detectable dose) of the assay kit is 0.1 ng/mL and it is determined experimentally by adding three standard deviations to the average optical density (OD) of twenty replicates of the zero standard and calculating the corresponding concentration. This illustrates the lowest concentration distinguishable from zero. were considered as 0.00 ng/mL. In the current study, we did not obtain values above the upper limit range.
HSP70 concentration was evaluated using a Biorbyt Human heat shock proteins (HSP70) ELISA kit (Catalogue No. Orb397059) in compliance with the manufacturer’s instructions. The detection range for the kit is between 125 and 8000 pg/mL. In the first experiment, peritoneal lavage fluid samples were not diluted prior to analysis. In this experiment, we received 36 results above the ELISA kit detection range (8000 pg/mL). Therefore, we repeated the experiment with 50-fold diluted peritoneal lavage fluid samples. Obtained results were multiplied by the dilution factor.
According to the manufacturer’s instruction, the sensitivity (minimum detectable dose) of the assay kit for HSP70 is 60 pg/mL and it is determined experimentally by adding three standard deviations to the average optical density (OD) of twenty replicates of the zero standard and calculating the corresponding concentration. This illustrates the lowest concentration distinguishable from zero. were considered as 0.00 ng/mL.
2.3. CRP and WBC Evaluation
During infection or inflammation C-reactive protein (CRP) concentration rises rapidly within the first 6 to 8 hours, while the peak is observed after 48 hours . Therefore, patients’ blood for CRP evaluation was collected twice: about 2 hours prior to surgery and 8-10 hours after conducted procedure. The same was done for white blood cell count (WBC) evaluation. In order to determine the CRP, the blood was collected into the test tubes with clotting activator (S-Monovette, SARSTEDT, 1.2 mL). Within 2 hours after the venipuncture, the blood was centrifuged to obtain serum samples and CRP was tested on the Cobas C501 (Roche Diagnostics) analyzer. In order to determine WBC on a XT 4000i (Sysmex) hematological analyzer, the blood was collected into the test tubes with EDTA-K3 (S-Monovette, SARSTEDT, 1.2 mL).
2.4. Data Analysis
Statistical analysis was performed using the STATISTICA PL release 12.5 Program. All the results are presented as median (Me) within the 25th and 75th percentiles (IQs). Data normality was analyzed using the Shapiro-Wilk test, which proved that IL-6 concentration in the peritoneal lavage fluid did not follow the normal distribution. Therefore, the differences in continuous variable values were assessed using the Mann-Whitney test and Wilcoxon matched pairs test which was used to test for significant differences between two conditions of an independent variable in an experiment where the same participants are responding in both groups (at the beginning and at the end of the surgery). Differences in baseline characteristics between two study groups were tested using the chi-square and Fisher exact test (categorical variables) or two-sample -test (continuous variables) (Table 1). Correlations were studied by using Spearman’s correlation test. Spearman’s correlation coefficient was used to assess the correlation strength. All tests were two-sided with a level of statistical significance ().
A value < 0.05 is considered to show a significant difference between groups. Warmed, humidified CO2 does not attenuate the early inflammatory cytokine response . Paracetamol has no influence on inflammatory response. N/A: not applicable.
Peritoneal lavage fluid samples were obtained from all children at the beginning and at the end of the laparoscopic and open cholecystectomy procedures.
For each patient, key data such as type of surgical procedure, surgery duration, surgical findings, and the presence of any different pathology and demographic data included age and gender are collected and summarized in Table 1 with values describing the comparability between two study groups. There were no significant differences between variables () except for surgery duration and length of hospital stay after surgery for children undergoing laparoscopic and open cholecystectomy ().
3.1. Peritoneal Lavage Fluid IL-6 Concentration Results
The IL-6 growth during open cholecystectomy was greater compared to laparoscopic cholecystectomy (62.51-fold vs. 3.19-fold). In the case of both laparoscopic and open cholecystectomy procedures, peritoneal lavage fluid IL-6 concentration was significantly higher measured at the end of the operation than at the beginning (, Table 2).
A value < 0.05 is considered to show a significant difference between groups (according to Wilcoxon matched pairs test).
Peritoneal lavage fluid IL-6 concentration strongly, positively correlated with the duration time of open cholecystectomy (; ) as well as very strongly, positively correlated with the duration time of laparoscopic cholecystectomy (; ). Thus, in the next step, we compared IL-6 concentration at the end of both types of cholecystectomy with comparable duration time of the procedure. Much higher IL-6 growth was observed at the end of open cholecystectomy lasting for about 2 hours () compared to the end of laparoscopic surgery with comparable duration time () (Figure 1). In the whole group of cholecystectomy children, IL-6 concentration strongly, positively correlated with the length of the hospitalization (; ).
3.2. Peritoneal Lavage Fluid HMGB1 and HSP70 Concentration Results
In laparoscopic surgery, peritoneal lavage fluid HMGB1 concentration was significantly higher when measured at the end of the operation than at the beginning (). In the group of open cholecystectomy children, HMGB1 concentration was almost the same at the beginning compared to the end of the procedure () (Table 3). In both surgery types, peritoneal lavage fluid HSP70 concentration was significantly higher measured at the end of the operation than at the beginning (, Table 3). Both HMGB1 and HSP70 concentrations, at the beginning and at the end of the procedures, did not correlate with IL-6 concentration (, respectively).
A value < 0.05 is considered to show a significant difference between groups (according to Wilcoxon matched pairs test). #All values below the sensitivity of the ELISA test were considered as 0.00 ng/mL for HMGB1 and 0.00 pg/mL for HSP70.
3.3. Blood CRP Concentration and WBC Results
Both CRP concentration and WBC in the blood were significantly higher 8-10 hours after applied procedures (laparoscopy and open surgery) as compared to the values obtained 2 hours prior to surgery (Table 4). Our study showed that CRP concentration measured after the open cholecystectomy increased 112.3-fold compared to the presurgery state. In the case of laparoscopic approach, 7.1-fold growth was observed. WBC value measured after the open cholecystectomy approach increased 1.7-fold compared to the initial state. In the case of laparoscopic surgery, growth was 1.5-fold.
A value < 0.05 is considered to show a significant difference between groups (according to Wilcoxon matched pairs test).
Observations based on this study are the first to show that a rapid and significant peritoneal lavage fluid IL-6 growth is already taking place during both laparoscopic and open cholecystectomy. However, IL-6 growth during open cholecystectomy was greater compared to laparoscopic cholecystectomy (62.51-fold vs. 3.19-fold). Our results are in line with other studies indicating increased inflammatory response in open surgery in comparison to the equivalent laparoscopic one [19–22, 36, 37].
This is also the first study which measured IL-6 concentration in peritoneal lavage fluid, obtained during cholecystectomy. Moreover, it should be noted that IL-6 concentration was measured on immunochemical analyzer used within routine laboratory diagnostics.
Numerous studies show that levels of circulating plasma proinflammatory cytokines, including IL-6, are related to the extent and severity of surgical procedure [18–22]. IL-6 concentration was mostly measured in plasma or serum [18–20]; rarely, it was assessed in peritoneum . Even if the authors present results of the IL-6 concentration in peritoneal lavage fluid, data concern the postsurgery IL-6 evaluation [20, 36–38]. On the contrary, our measurements were conducted twice: at the beginning and at the end of cholecystectomy. Kumagai et al.  and Sammour et al.  postulate that IL-6 is a reasonable and reliable parameter for assessment of surgical stress up to 24 hours after surgery, because during this time it is mostly released into the peritoneal cavity. Zhang et al.  found that IL-6 is increased within 6 hours after surgery.
In the current study, we demonstrated that IL-6 concentration in peritoneal lavage fluid grows in the first hours of the operation; however, the growth in open procedure was much higher compared to laparoscopy. This subject has not been widely studied so far, as only Kawashima et al.  showed that the concentration of IL-6 in peritoneal lavage fluid was 11-fold higher at the end of the operation than immediately after incision at the beginning of the surgery. In our opinion, the difference regarding IL-6 results (11-fold growth vs. 3.19-fold growth) between Kawashima et al. and our study may result from (1) different methods applied for IL-6 evaluation (Kawashima et al. used the multiplex Bio-Plex Suspension Array System) (Bio-Rad Japan, Tokyo, Japan); multiplex method evaluating many ligands simultaneously in the same sample can lead to a cross reaction ; we chose the IVD test using electrochemiluminescence immunoassay (ECLIA) method (Roche Diagnostics); (2) different procedures being evaluated (Kawashima et al. studied IL-6 concentration in peritoneal cavity only during laparotomy; we analyzed both procedures, laparoscopy and open surgery); (3) different numbers of cases (Kawashima et al. , our group and ); (4) different studied groups (adults versus children and cancer patients versus nontumoral individuals).
A few earlier findings suggest that IL-6 concentration correlates with clinical parameters including length of surgery and length of hospitalization [19, 38, 42]. This was also confirmed by our study, as peritoneal lavage fluid IL-6 concentration is strongly, positively correlated with the duration time of cholecystectomy. Moreover, we noted a significant difference in IL-6 concentration between patients that underwent laparoscopic and open cholecystectomy just about 2 hours from the beginning of the operation. This is in line with findings of Shietroma et al. [43, 44], who observed that blood IL-6 concentration began to significantly increase as early as 1 hour from the beginning of the operation. Current results also confirmed the concept, presented by other authors [19, 36, 38, 42], that IL-6 concentration is very strongly and positively correlated with the hospital stay after surgery.
Our previous experiment showed that open surgical procedure is connected with more invasive tissue damage and in consequence with stronger inflammatory response compared to laparoscopic one . Thus, in the next step, we analyzed the peritoneal lavage fluid concentrations of selected DAMPs: HMGB1 and HSP70 to find out if the source of IL-6 was related to the tissue damage. In our study IL-6 concentration did not correlate neither with HMGB1 nor with HSP70 concentration, which indicates that the significant growth of this protein was not related to surgical tissue injury.
Recently, HMGB1 has been identified as a mediator of lethal systemic inflammation and local inflammation . Studies show that HMGB1 release by activated macrophages is created by active translocation from the nucleus to the cytoplasm, rather than by cell death [47–49]. HMGB1 can also be released by damaged or necrotic cells as a result of tissue injury or trauma . In our study, a significant difference in HMGB1 concentration between beginning versus the end of the procedure was found only in laparoscopic cholecystectomy. Concentration of this protein in the case of open surgery was higher already after incision but did not change during operation. An explanation of our current findings could be delayed HMGB1 kinetics during the immune response , as mice exposed to endotoxin did not have detectable blood HMGB1 concentrations before 8 hours . Moreover, Maca et al.  found that, except for HMGB1, the levels of other circulating DAMPs were higher in the group of major abdominal surgery patients as compared to the nonsurgical group. Thus, we conclude that peritoneal lavage fluid HMGB1 concentration measurement in children undergoing cholecystectomy would not be useful to evaluate an early immune response to tissue damage during surgery.
Heat shock proteins (HSPs), commonly referred to as “stress proteins,” provide protection against cellular and environmental stress factors [52, 53]. Extracellular or membrane-bound HSP70 and HSP90 have the ability to affect the release of cytokines, including IL-6 [54–56]. In our study, peritoneal lavage fluid HSP70 concentration was significantly higher when measured at the end of the operation than at the beginning, in case of both surgery types (laparoscopy and open surgery). Indeed, Mendoza-Sagaon et al.  indicate that there are no significant differences between laparoscopy and open cholecystectomy in terms of induction of the stress response, as steady-state mRNA levels of HSP70 were not significantly changed after both surgeries. However, it should be mentioned that their study was conducted on liver biopsies obtained from pigs. According to our best knowledge, our study is the first which evaluates HSP70 concentrations in peritoneal lavage fluid of children undergoing cholecystectomy. On the contrary, Braun et al.  found that among others IL-6 and HSP70 are parameters of early mRNA expression during intestinal ischemia-reperfusion injury in pigs. Expression of IL-6 mRNA increased at 2 hours after reperfusion and HSP70 at 3 hours after reperfusion. These results in general are consistent with our study, as we showed that HSP70 growth occurred in the first hours in response to surgical injury.
One of the study limitations could be a small number of children undergoing open cholecystectomy. However, it was due to that laparoscopic approach optimizes outcome, even though it has higher risk of bile duct injury than the classical open technique. Thus, the small number of samples obtained during open cholecystectomy reflects the tendency among surgeons to choose laparoscopic approach over the classical surgical cholecystectomy. Another study limitation is that we collected and preserved only peritoneal lavage fluid to assess early local response in the peritoneum to the surgical injury during the first hours. We did not measure serum IL-6. However, the main aim of our study was concentrated on the intraperitoneal immune response.
To conclude, our results demonstrated significant peritoneal lavage fluid IL-6 concentration growth measured at the end of the cholecystectomy as compared to the beginning, regardless of the type of the procedure. IL-6 growth during open cholecystectomy was greater compared to laparoscopic cholecystectomy. IL-6 concentration did not correlate with HMGB1 and HSP70, which indicate that the significant growth of this cytokine was not related only to mechanical tissue damage due to surgical procedure.
A clinical significance of the study could be related to the fact that the evaluation of IL-6 concentration in peritoneal lavage fluid by IVD test may be useful to assess an early local inflammatory response and help indicate individuals, which gain benefits from targeted intraperitoneal anti-IL-6 monoclonal antibody therapy. However, this aspect remains for further studies.
The datasets generated and analyzed during the current study are not publicly available but all are kept at the Medical University of Bialystok and available from the corresponding author on reasonable request.
Approval for this study was obtained from Bioethics Committee of Medical University of Białystok (Permission No.: R-I-002/471/2018). Procedures were in accordance with the ethical standards set by the Declaration of Helsinki given by the World Medical Association.
We have received consent from individual patients who have participated in the present study.
Conflicts of Interest
The authors declare that they have no conflicts of interest.
MT did the conceptualization, investigation, funding acquisition, formal analysis, resources, visualization, and writing the original draft. EM did the resources, investigation, visualization, writing the review, and editing. JK did the resources, investigation, methodology, writing the review, and editing. WD did the resources, investigation, writing the review, and editing. BM did the supervision, writing the review, and editing. TK did the supervision, writing the review, and editing. VD-P did the funding acquisition, resources, methodology, writing the review, and editing. JM-K did the funding acquisition, resources, supervision, writing the review, and editing. MK did the visualization, supervision, writing the review, and editing. OMK-L did the conceptualization, investigation, funding acquisition, formal analysis, resources, visualization, writing the original draft, and supervision.
We are grateful to Martin Lenkiewicz, MSc, for his language assistance.
- C. P. Rubert, R. A. Higa, and F. V. B. Farias, “Comparison between open and laparoscopic elective cholecystectomy in elderly, in a teaching hospital,” Revista do Colégio Brasileiro de Cirurgiões, vol. 43, no. 1, pp. 2–005, 2016.
- A. Gangji, M. Porwal, A. Gupta, and A. Chauhan, “Comparative study between laparoscopic and open cholecystectomy in respect of postoperative recovery and hospital stay,” Journal of Evolution of Medical and Dental Sciences., vol. 3, no. 5, pp. 1089–1096, 2014.
- A. Hermanowicz, E. Matuszczak, M. Komarowska et al., “Laparoscopy-assisted percutaneous endoscopic gastrostomy enables enteral nutrition even in patients with distorted anatomy,” World Journal of Gastroenterology, vol. 19, no. 43, pp. 7696–7700, 2013.
- M. Tylicka, E. Matuszczak, M. Karpińska, A. Hermanowicz, W. Dębek, and H. Ostrowska, “Proteasome and C-reactive protein inflammatory response in children undergoing shorter and longer lasting laparoscopic cholecystectomy,” Scandinavian Journal of Clinical and Laboratory Investigation, vol. 77, no. 8, pp. 610–616, 2017.
- D. E. Fry, M. Pine, S. M. Nedza, A. M. Reband, C. J. Huang, and G. Pine, “Comparison of risk-adjusted outcomes in medicare open versus laparoscopic cholecystectomy,” The American Surgeon, vol. 84, no. 1, pp. 12–19, 2018.
- J. Máca, M. Peteja, P. Reimer et al., “Surgical injury: comparing open surgery and laparoscopy by markers of tissue damage,” Therapeutics and Clinical Risk Management, vol. 14, pp. 999–1006, 2018.
- T. Tanaka, M. Narazaki, and T. Kishimoto, “IL-6 in inflammation, immunity, and disease,” Cold Spring Harbor Perspectives in Biology, vol. 6, no. 10, article a016295, 2014.
- V. Dymicka-Piekarska, H. Kemona, and K. Guzinska-Ustymowicz, “Does surgery affect certain mediators of thrombocytopoiesis in patients with colorectal cancer,” Hepato-Gastroenterology, vol. 54, no. 77, pp. 1407–1411, 2007.
- N. Vainer, C. Dehlendorff, and J. S. Johansen, “Systematic literature review of IL-6 as a biomarker or treatment target in patients with gastric, bile duct, pancreatic and colorectal cancer,” Oncotarget, vol. 9, no. 51, pp. 29820–29841, 2018.
- E. Matuszczak, M. Tylicka, W. Dębek, A. Tokarzewicz, E. Gorodkiewicz, and A. Hermanowicz, “Concentration of UHCL1 in the serum of children with acute appendicitis, before and after surgery, and its correlation with CRP and prealbumin,” Journal of Investigative Surgery, vol. 31, no. 2, pp. 136–141, 2017.
- Y. C. Cheong, S. M. Laird, J. B. Shelton, W. L. Ledger, T. C. Li, and I. D. Cooke, “The correlation of adhesions and peritoneal fluid cytokine concentrations: a pilot study,” Human Reproduction, vol. 17, no. 4, pp. 1039–1045, 2002.
- A. A. Saba, A. A. Kaidi, V. Godziachvili et al., “Effects of interleukin-6 and its neutralizing antibodies on peritoneal adhesion formation and wound healing,” The American Surgeon, vol. 62, no. 7, pp. 569–572, 1996.
- W. G. Land, “The role of damage-associated molecular patterns (DAMPs) in human diseases: part II: DAMPs as diagnostics, prognostics and therapeutics in clinical medicine,” Sultan Qaboos University Medical Journal, vol. 15, no. 2, pp. e157–e170, 2015.
- S. Chaudhry, A. Hafez, B. R. Jahromi et al., “Role of damage associated molecular pattern molecules (DAMPs) in aneurysmal subarachnoid hemorrhage (aSAH),” Int J Mol Sci, vol. 19, no. 7, p. 2035, 2018.
- G. Srikrishna and H. H. Freeze, “Endogenous damage-associated molecular pattern molecules at the crossroads of inflammation and cancer,” Neoplasia, vol. 11, no. 7, pp. 615–628, 2009.
- M. E. Bianchi, “DAMPs, PAMPs and alarmins: all we need to know about danger,” Journal of Leukocyte Biology, vol. 81, no. 1, pp. 1–5, 2007.
- N. Fink-Neuboeck, J. Lindenmann, S. Bajric et al., “Clinical impact of interleukin 6 as a predictive biomarker in the early diagnosis of postoperative systemic inflammatory response syndrome after major thoracic surgery: a prospective clinical trial,” Surgery, vol. 160, no. 2, pp. 443–453, 2016.
- J. M. Luk, P. H. Tung, K. F. Wong, K. L. Chan, S. Law, and J. Wong, “Laparoscopic surgery induced interleukin-6 levels in serum and gut mucosa: implications of peritoneum integrity and gas factors,” Surgical Endoscopy, vol. 23, no. 2, pp. 370–376, 2009.
- Y. Kumagai, Y. Tajima, T. Ishiguro et al., “Production of intraperitoneal interleukin-6 following open or laparoscopic assisted distal gastrectomy,” International Surgery, vol. 99, no. 6, pp. 812–818, 2014.
- J. Ordemann, C. A. Jacobi, W. Schwenk, R. Stösslein, and J. M. Müller, “Cellular and humoral inflammatory response after laparoscopic and conventional colorectal resections,” Surgical Endoscopy, vol. 15, no. 6, pp. 600–608, 2001.
- M. W. Wichmann, T. P. Hüttl, H. Winter et al., “Immunological effects of laparoscopic vs open colorectal surgery: a prospective clinical study,” Archives of Surgery, vol. 140, no. 7, pp. 692–697, 2005.
- S. Mijatovic, B. Stefanovic, V. Jeremic et al., “Evaluation of serum cytokines levels in patients undergoing laparoscopic versus conventional cholecystectomy,” The Journal of Pharmacy and Pharmacology, vol. 4, pp. 10–16, 2016.
- M. R. Shalaby, A. Waage, L. Aarden, and T. Espevik, “Endotoxin, tumor necrosis factor-α and interleukin 1 induce interleukin 6 production in vivo,” Clinical Immunology and Immunopathology, vol. 53, no. 3, pp. 488–498, 1989.
- A. Shenkin, W. D. Fraser, J. Series et al., “The serum interleukin 6 response to elective surgery,” Lymphokine Research, vol. 8, no. 2, pp. 123–127, 1989.
- A. M. Cruickshank, W. D. Fraser, H. J. G. Burns, J. van Damme, and A. Shenkin, “Response of serum interleukin-6 in patients undergoing elective surgery of varying severity,” Clinical Science, vol. 79, no. 2, pp. 161–165, 1990.
- L. E. DeForge and D. G. Remick, “Kinetics of TNF, IL-6, and IL-8 gene expression in LPS-stimulated human whole blood,” Biochemical and Biophysical Research Communications, vol. 174, no. 1, pp. 18–24, 1991.
- S. Hedges, P. Anderson, G. Lidin-Janson, P. de Man, and C. Svanborg, “Interleukin-6 response to deliberate colonization of the human urinary tract with gram-negative bacteria,” Infection and Immunity, vol. 59, no. 1, pp. 421–427, 1991.
- U. Ikeda, F. Ohkawa, Y. Seino et al., “Serum interleukin 6 levels become elevated in acute myocardial infarction,” Journal of Molecular and Cellular Cardiology, vol. 24, no. 6, pp. 579–584, 1992.
- H. Ueo, M. Honda, M. Adachi et al., “Minimal increase in serum interleukin-6 levels during laparoscopic cholecystectomy,” American Journal of Surgery, vol. 168, no. 4, pp. 358–360, 1994.
- P. Keller, C. Keller, A. L. Carey et al., “Interleukin-6 production by contracting human skeletal muscle: autocrine regulation by IL-6,” Biochemical and Biophysical Research Communications, vol. 310, no. 2, pp. 550–554, 2003.
- Y. Yamamoto, M. Kurachi, K. Yamaguchi, and T. Oda, “Stimulation of multiple cytokine production in mice by alginate oligosaccharides following intraperitoneal administration,” Carbohydrate Research, vol. 342, no. 8, pp. 1133–1137, 2007.
- F. Braun, M. Hosseini, E. Wieland et al., “Kinetics and localization of interleukin-2, interleukin-6, heat shock protein 70, and interferon gamma during intestinal-rerfusion injury,” Transplantation Proceedings, vol. 36, no. 2, pp. 267–269, 2004.
- A. Alloui, C. Chassaing, J. Schmidt et al., “Paracetamol exerts a spinal, tropisetron-reversible, antinociceptive effect in an inflammatory pain model in rats,” European Journal of Pharmacology, vol. 443, no. 1-3, pp. 71–77, 2002.
- O. M. Koper-Lenkiewicz, J. Kamińska, A. Milewska et al., “Serum and cerebrospinal fluid Neudesin concentration and Neudesin Quotient as potential circulating biomarkers of a primary brain tumor,” BMC Cancer, vol. 19, no. 1, p. 319, 2019.
- WHO/NMH/NHD/EPG/14.7, “C-reactive protein concentrations as a marker of inflammation or infection for interpreting biomarkers of micronutrient status. Vitamin and Mineral Nutrition Information System,” Tech. Rep., World Health Organization, Geneva, 2014, November 2019, WHO/NMH/NHD/EPG/14.7; http://apps.who.int/iris/bitstream/10665/133708/1/WHO_NMH_NHD_EPG_14.7_eng.pdf?ua=1.
- T. Sammour, A. Kahokehr, K. Zargar-Shoshtari, and A. G. Hill, “A prospective case-control study of the local and systemic cytokine response after laparoscopic versus open colonic surgery,” The Journal of Surgical Research, vol. 173, no. 2, pp. 278–285, 2012.
- A. Tokunaga, M. Onda, I. Fujita et al., “Sequential changes in the cell mediators of peritoneal and wound fluids after surgery,” Surgery Today, vol. 23, no. 9, pp. 841–844, 1993.
- K. Jansson, B. Redler, L. Truedsson et al., “Intraperitoneal cytokine response after major surgery: higher postoperative intraperitoneal versus systemic cytokine levels suggest the gastrointestinal tract as the major source of the postoperative inflammatory reaction,” American Journal of Surgery, vol. 187, no. 3, pp. 372–377, 2004.
- W. R. Zhang, A. X. Garg, S. G. Coca et al., “Plasma IL-6 and IL-10 concentrations predict AKI and long-term mortality in adults after cardiac surgery,” Journal of the American Society of Nephrology, vol. 26, no. 12, pp. 3123–3132, 2015.
- R. Kawashima, Y. I. Kawamura, T. Oshio et al., “Comprehensive analysis of chemokines and cytokines secreted in the peritoneal cavity during laparotomy,” Journal of Immunoassay & Immunochemistry, vol. 33, no. 3, pp. 291–301, 2012.
- O. M. Koper, J. Kamińska, H. Kemona, and V. Dymicka-Piekarska, “Application of the bead-based technique in neurodegeneration: a literature review,” Neurodegenerative Diseases, vol. 15, no. 5, pp. 281–293, 2015.
- T. Yamamoto, S. Umegae, K. Matsumoto, and A. R. Saniabadi, “Peritoneal cytokines as early markers of peritonitis following surgery for colorectal carcinoma: a prospective study,” Cytokine, vol. 53, no. 2, pp. 239–242, 2011.
- M. Schietroma, F. Carlei, A. Mownah et al., “Changes in the blood coagulation, fibrinolysis, and cytokine profile during laparoscopic and open cholecystectomy,” Surgical Endoscopy, vol. 18, no. 7, pp. 1090–1096, 2004.
- M. Shietroma, A. Giulani, L. Lely, F. Carlei, A. Pescosolido, and G. Amicucci, “Changes in blood coagulation, fibrynolysis and cytokine profile during laparoscopic and open cholecystectomy,” Chirurgia Italiana, vol. 60, no. 2, pp. 179–188, 2008.
- M. Tylicka, E. Matuszczak, M. Karpińska, A. Hermanowicz, W. Dębek, and H. Ostrowska, “Proteasome activity and C-reactive protein concentration in the course of inflammatory reaction in relation to the type of abdominal operation and the surgical technique used,” Mediators of Inflammation, vol. 2018, Article ID 2469098, 8 pages, 2018.
- H. Wang, H. Yang, and K. J. Tracey, “Extracellular role of HMGB1 in inflammation and sepsis,” Journal of Internal Medicine, vol. 255, no. 3, pp. 320–331, 2004.
- H. Wang, O. Bloom, M. Zhang et al., “HMG-1 as a late mediator of endotoxin lethality in mice,” Science, vol. 285, no. 5425, pp. 248–251, 1999.
- H. Wang, J. M. Vishnubhakat, O. Bloom et al., “Proinflammatory cytokines (tumor necrosis factor and interleukin 1) stimulate release of high mobility group protein-1 by pituicytes,” Surgery, vol. 126, no. 2, pp. 389–392, 1999.
- B. Rendon-Mitchell, M. Ochani, J. Li et al., “IFN-gamma induces high mobility group box 1 protein release partly through a TNF-dependent mechanism,” Journal of Immunology, vol. 170, no. 7, pp. 3890–3897, 2003.
- A. O'Callaghan, J. Wang, and H. P. Redmond, “HMGB1 as a key mediator of tissue response to injury: roles in inflammation and tissue repair,” European Surgery, vol. 38, no. 4, pp. 283–292, 2006.
- J. Maca, M. Holub, F. Bursa et al., “Alarmins as biomarkers of gastrointestinal surgical injury – a pilot study,” APMIS, vol. 126, no. 2, pp. 152–159, 2018.
- A. Kaźmierczuk and Z. M. Kiliańska, “The pleiotropic activity of heat-shock proteins,” Postȩpy Higieny i Medycyny Doświadczalnej (Online), vol. 63, pp. 502–521, 2009.
- R. Polanowska-Grabowska and A. R. L. Gear, “Heat-shock proteins and platelet function,” Platelets, vol. 11, no. 1, pp. 6–22, 2009.
- A. Asea, S. K. Kraeft, E. A. Kurt-Jones et al., “HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine,” Nature Medicine, vol. 6, no. 4, pp. 435–442, 2000.
- A. Asea, M. Rehli, E. Kabingu et al., “Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4,” The Journal of Biological Chemistry, vol. 277, no. 17, pp. 15028–15034, 2002.
- T. Lehner, Y. Wang, T. Whittall, E. McGowan, C. G. Kelly, and M. Singh, “Functional domains of HSP70 stimulate generation of cytokines and chemokines, maturation of dendritic cells and adjuvanticity,” Biochemical Society Transactions, vol. 32, no. 4, pp. 629–632, 2004.
- M. Mendoza-Sagaon, E. J. Hanly, M. A. Talamini et al., “Comparison of the stress response after laparoscopic and open cholecystectomy,” Surgical Endoscopy, vol. 14, no. 12, pp. 1136–1141, 2000.
Copyright © 2020 Marzena Tylicka et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.